FOXO1 and neoplasm: This is evident in the CCL20/CCR6 axis as its overexpression in resistant patients has been associated with increased TFCD4+ infiltration from tumor-infiltrating lymphocytes (TILs) via forkhead box protein O1 (FOXO1)/CEBPB/NF-κB pathway [151].